SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $639,000 | -56.4% | 26,940 | -49.5% | 0.04% | -47.1% |
Q3 2019 | $1,466,000 | -48.1% | 53,345 | -37.5% | 0.07% | -44.4% |
Q2 2019 | $2,823,000 | -6.2% | 85,320 | -0.7% | 0.13% | +8.6% |
Q1 2019 | $3,011,000 | +5.5% | 85,935 | 0.0% | 0.12% | +0.9% |
Q4 2018 | $2,855,000 | -36.5% | 85,935 | -3.8% | 0.12% | -12.9% |
Q3 2018 | $4,497,000 | -13.0% | 89,305 | +3.4% | 0.13% | -16.5% |
Q2 2018 | $5,167,000 | – | 86,340 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |